This article is more than 5 years old. Information may no longer be current.
Intervention improves adherence to Mediterranean diet, intermittent statin dosing shows promise — top stories in cardiology
Click Here to Manage Email Alerts
A JAMA study showing how an intervention improved adherence to the Mediterranean diet was one of the top stories in cardiology last week.
Other top cardiology stories included a study on intermittent dosing, which helped to address patients’ intolerance to statins, and findings demonstrating the impact that lipoprotein(a) has on CVD risk.
Intervention improves adherence to Mediterranean diet
An intervention promoting an energy-reduced Mediterranean diet and physical activity was linked to better adherence to the Mediterranean diet at 1 year compared with the traditional Mediterranean diet in individuals with metabolic syndrome, according to interim results published in JAMA. Read more.
Statin intolerance can be fought with intermittent dosing
Intermittent statin dosing is a treatment option that may have tremendous potential for addressing patients with statin intolerance who are trying to reduce LDL, according to a speaker at the Cardiometabolic Health Congress. Read more.
Lipoprotein(a) has strong effect on CVD risk
According to a presentation at the Cardiometabolic Health Congress, lipoprotein(a) has been shown to be an independent, causal and genetic risk factor for CVD, with higher prevalence in patients of African, South Asian, Asian and Oceanic ancestry. Read more.
Metabolic syndrome may play role in heart failure with preserved ejection fraction risk
Patients with metabolic syndrome are at risk for developing heart failure with preserved ejection fraction, although the mechanisms behind this risk are speculative at the moment, according to a presentation at the Cardiometabolic Health Congress. Read more.
Angiotensin receptor blockers may increase risk for suicide
Patients treated with angiotensin receptor blockers had an increased risk for suicide compared with those treated with angiotensin-converting-enzyme inhibitors, according to a study published in JAMA Network Open. Read more.